News and Announcements

Oxford Biomedica shares tank after FY sales, margin guidance slashed

By Frank Prenesti

Date: Friday 07 Aug 2026

(Sharecast News) - Shares in Oxford Biomedica tanked by a quarter on Friday after the cell and gene therapy manufacturer slashed its full year revenue and margins forecast citing short‑term client ordering delays, programme deferrals and operational delays at its North Carolina facility.


The company now expects 2026...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page